BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Prime Therapeutics Named Exclusive Pharmacy Benefit Manager for HR Policy Association


8/23/2012 10:46:56 AM

ST. PAUL, Minn., Aug. 21, 2012 /PRNewswire/ -- Prime Therapeutics (Prime), a leading pharmacy benefit manager (PBM), has been selected as the exclusive PBM and third party administrator for the HR Policy Association's Pharmaceutical Coalition, the lead organization representing chief human resource officers of more than 330 of the largest corporations in the United States and globally. Through the new program, members of the coalition will have a fully transparent contractual agreement.

The new program passes on the cost of drugs and all financial benefits accrued directly to the employer, and costs will be fully transparent. This is unlike most traditional PBM relationships, due to misaligned contractual elements the employer doesn't know the actual costs of the drug paid by the PBM or the mark-ups added to that cost. The program will be available to coalition employers beginning January 1, 2013.

"Our new agreement with HR Policy Association's Pharmaceutical Coalition not only serves as a strong reinforcement of our continued commitment to transparency for all of our clients, it also confirms that we are a highly competitive player in the large employer market," said Eric Elliott, Prime president and CEO. "While we continue to be committed to an integrated medical and pharmacy model, we welcome the opportunity to expand access to Prime's high-quality, affordable pharmacy management to current and future HR Policy members. We believe this agreement will only strengthen our impact in this market as more and more customers realize the importance of Prime's unique value proposition."

Since 2006, the Coalition has been actively involved in increasing transparency in the PBM industry, through its Transparency in Pharmaceutical Purchasing Solutions (TIPPS) certification program. PBMs willing to meet high standards of transparency can receive annual certification. Prime was among the first PBMs to participate in the TIPPS initiative. It has received certification each year, including the highest level of certification last year.

"The HR Policy Association's Pharmaceutical Coalition program will now make it easier than ever for employers to provide affordable, quality prescription drug benefits to employees, retirees and their dependents." said Jeffrey C. McGuiness, Chief Executive Officer of the Association. "The Coalition is looking forward to working with Prime Therapeutics to advance the HR Policy Association's long-term goal of promoting transparency in pharmacy benefits."

Prime Therapeutics is a pharmacy benefit management company dedicated to providing innovative, clinically-based, cost-effective pharmacy solutions for clients and customers. Providing pharmacy benefit services nationwide to nearly 20 million lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minn., Prime Therapeutics is collectively owned by 13 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at www.primetherapeutics.com.

SOURCE Prime Therapeutics



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES